Published in TB and Outbreaks Week, February 8th, 1999
The Finnish National Public Health Institute in Helsinki, Finland, conducts the study in 500 children. The double-blind, placebo-controlled trial is designed to evaluate the effectiveness and safety of multiple intranasal doses of NE-1530 in the prevention of pediatric ear infections during a three-month course of treatment.
The study also evaluates changes in colonization of the bacteria that are primarily responsible for pediatric ear infections. Phase I...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week